AU2003302070A1 - USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFBeta - Google Patents

USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFBeta

Info

Publication number: AU2003302070A1
Authority: AU; Australia
Prior art keywords: tgfbeta; potentiating; action; receptor antagonist; rar receptor
Prior art date: 2002-11-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003302070A

Inventor

Michel Demarchez

Andre Jomard

Alain Mauviel

Serge Michel

Valerie Pendaries

Franck VERRECCHIA

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Galderma Research and Development SNC

Original Assignee

Galderma Research and Development SNC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-15

Filing date

2003-11-14

Publication date

2004-06-15

2002-11-15 Priority claimed from FR0214319A external-priority patent/FR2847167A1/en

2003-11-14 Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC

2004-06-15 Publication of AU2003302070A1 publication Critical patent/AU2003302070A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AU2003302070A 2002-11-15 2003-11-14 USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFBeta Abandoned AU2003302070A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
FR02/14319		2002-11-15
FR0214319A FR2847167A1 (en)	2002-11-15	2002-11-15	USE OF AN ANTAGONIST OF RAR RECEPTORS TO POTENTIALIZE THE ACTION OF TGFb
US43067102P	2002-12-04	2002-12-04
US60/430,671		2002-12-04
PCT/EP2003/014864 WO2004045595A1 (en)	2002-11-15	2003-11-14	USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFβ

Publications (1)

Publication Number	Publication Date
AU2003302070A1 true AU2003302070A1 (en)	2004-06-15

Family

ID=32327936

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003302070A Abandoned AU2003302070A1 (en)	2002-11-15	2003-11-14	USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFBeta

Country Status (2)

Country	Link
AU (1)	AU2003302070A1 (en)
WO (1)	WO2004045595A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2208844A1 (en) *	1994-12-29	1996-07-11	Alan T. Johnson	Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
FR2753627B1 (en) *	1996-09-20	2003-02-21	Galderma Rech Dermatologique	USE OF INHIBITORS OF RETINOIC ACID ACTIVITY TO PROMOTE HEALING
FR2755011B1 (en) *	1996-10-31	1998-11-20	Cird Galderma	USE OF INHIBITORS OF RETINOIC ACID ACTIVITY TO TREAT SENSITIVE SKIN AND / OR ACUTE DAMAGE INDUCED BY U.V. RADIATION
WO1998046223A1 (en) *	1997-04-11	1998-10-22	Bristol-Myers Squibb Company	Retinoid antagonists for prevention of surgical adhesions
US6313168B1 (en) *	1999-12-15	2001-11-06	Allergan Sales, Inc.	Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies

2003
- 2003-11-14 AU AU2003302070A patent/AU2003302070A1/en not_active Abandoned
- 2003-11-14 WO PCT/EP2003/014864 patent/WO2004045595A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2004045595A1 (en)	2004-06-03

Similar Documents

Publication	Publication Date	Title
EP1576112A3 (en)	2005-09-01	Cytokine receptor zcytor17 multimers
AU2003261251A1 (en)	2004-02-23	Methods of delivering therapeutic agents
AU2003241836A1 (en)	2004-04-23	Lpa receptor antagonists
IL189657A0 (en)	2008-06-05	N-phenyl-2-pyrimidine-amine derivatives
AU2003231513A1 (en)	2003-12-02	Pgd2 receptor antagonist
AU2003288640A1 (en)	2004-07-22	Benzamide inhibitors of the p2x7 receptor
AU2003255501A1 (en)	2004-04-30	Cxcr4 receptor antagonists
AU2003294318A1 (en)	2004-06-15	Therapeutic bioconjugates
AU2003274307A1 (en)	2004-05-04	5-ht 1b/1d receptor agonists for the treatment of headache resulting from administering an endothelin receptor antagonist
AU2003267088A1 (en)	2004-04-30	Chemokine receptor antagonists as therapeutic agents
AU2002365655A1 (en)	2003-06-17	5-ht7 receptor antagonists
AU2003279841A1 (en)	2004-05-04	Uses of human zven antagonists
AU2003260072A1 (en)	2004-03-19	Antagonists of chemokine receptors
AU2002367730A1 (en)	2003-09-09	Use of leukotriene receptor antagonist for treatment of scarring
AU2003220466A1 (en)	2004-04-19	Delayed release dosage forms
AU2003300904A1 (en)	2004-07-09	Antagonists for human prolactin
AU2003240705A1 (en)	2003-12-02	Morpholinylmethylureas ccr-3 receptor antagonists
AU2003302070A1 (en)	2004-06-15	USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFBeta
AU2003288857A1 (en)	2004-07-09	New substituted 1-phenyl-tetrahydronaphtalene derivatives and their use as inhibitors of igf-1 receptor
AU2003259759A1 (en)	2004-02-25	Gal3 receptor antagonists for the treatment of affective disorders
AU2003279180A1 (en)	2004-01-06	Potentiating the antipyretic action of nonopioid analgesic
AU2003267800A1 (en)	2004-05-25	Methods of using ccr1 antagonists as immunomodulatory agents
AU2003300867A1 (en)	2004-07-29	Uses of the snorf207 receptor
AU2003240730A1 (en)	2003-12-12	Morpholinylmethylureas ccr-3 receptor antagonist
AU2003245995A1 (en)	2004-01-19	Use of gaba-c receptor antagonists for the treatment of myopia

Legal Events

Date	Code	Title	Description
2005-09-22	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase